Research and Markets: Global Mild Cognitive Impairment Pipeline Review H2 2015 - 11 Companies & 21 Drug Profiles

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/78g58p/mild_cognitive) has announced the addition of the "Mild Cognitive Impairment - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Mild cognitive impairment, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Mild cognitive impairment and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • Actinogen Limited
  • Avraham Pharmaceuticals Ltd.
  • Boehringer Ingelheim GmbH
  • CereSpir Incorporated
  • D-Pharm Ltd.
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Octapharma AG
  • Sage Therapeutics
  • Sanofi
  • Suven Life Sciences Ltd.

Drug Profiles

  • BAN-2401
  • BCA-909
  • CSP-1103
  • DAOI-B
  • DP-NDD
  • immune globulin (human)
  • insulin (human)
  • ladostigil tartrate
  • levetiracetam
  • LY-3002813
  • SAGE-547
  • SAR-228810
  • Small Molecule to Antagonize nAChR Alpha-4 Beta-2 for CNS Disorders
  • SUVN-501
  • SUVN-502
  • SUVN-507
  • SUVN-512
  • SUVN-976
  • SUVND-4010
  • tropisetron hydrochloride
  • UE-2343

For more information visit http://www.researchandmarkets.com/research/78g58p/mild_cognitive

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System